Rybelsus® approved in Japan for the treatment of type 2 diabetes ... Read more

Novo Nordisk successfully completes AM833 phase 2 trial and phase 1 combination ... Read more

Semaglutide 2.4 mg shows superior weight loss versus placebo in the phase 3 tria ... Read more

Novo Nordisk to acquire Corvidia Therapeutics and expand presence in cardiovascu ... Read more

Novo Nordisk A/S – Share repurchase programme ... Read more

Rybelsus® approved in Japan for the treatment of type 2 diabetes ... Read more

Novo Nordisk A/S – Share repurchase programme ... Read more

Novo Nordisk successfully completes AM833 phase 2 trial and phase 1 combination ... Read more

Financial statement for the first six months of 2020,

Silent period,

Financial statement for the first nine months of 2020,

Commerzbank Sector Conference , Frankfurt